Clinical trial
HighCycle: Effect of Acetazolamide on Pulmonary Artery Pressure in Women Compared to Men. A Randomized, Placebo-Controlled, Double-Blind Parallel Trial.
NCT06498505 is registered in ClinicalTrials.gov with University of Zurich as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- HighCycle: Effect of Acetazolamide on Pulmonary Artery Pressure in Women Compared to Men. A Randomized, Placebo-Controlled, Double-Blind Parallel Trial.
- Lead sponsor
- University of Zurich
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 15, 2024
- Completion date
- August 31, 2025
- Enrollment
- 303 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
high altitude